Batmunkh T, Neal EFG, Amraa O, Mazarakis N, et al. Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial. Vaccine 2025;66:127840.
PMID: 41072276